BiomarkerBase is focused on leveraging sophisticated machine learning techniques to read public sources of information and collect, analyze and categorize the world’s biomarker knowledge. We use these algorithms to draw conclusions about the usefulness of biomarkers to your programs as described in the published literature and to determine whether or not the biomarker is measured (as opposed to just mentioned). That allows us to deliver to you the most relevant evidence for setting effective biomarker strategies with efficiency.
Amplion’s pharmaceutical and diagnostic clients have accelerated their biomarker- associated research by 50% or more and increased clinical program success rates by up to 3x over previous methods.
BiomarkerBase™ is a web-based, self-service biomarker intelligence solution providing a comprehensive landscape of clinical biomarker usage and emerging or novel biomarkers. Biomarkerbase keeps your focus on the most evidence-based, well-validated and commercially viable opportunities.
Providing insights into:
With over 1.2M new publications each year and exponential growth in biomarker research it’s impossible to keep up. Uncovering novel, emerging biomarkers to drive innovation is incredibly difficult. Eliminating blind spots in your biomarker strategies is challenging without leveraging a machine learning powered approach.
Amplion’s BiomarkerBase efficiently delivers the biomarker intelligence you need for a comprehensive biomarker strategy that will drive the success of your programs.